Cita APA

Villar, J. C., Herrera, V. M., Pérez Carreño, J. G., Váquiro Herrera, E., Castellanos Domínguez, Y. Z., Vásquez, S. M., . . . Hernández, Y. (2019). Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): Study protocol for a randomised controlled trial. Web

Citación estilo Chicago

Villar, Juan Carlos, Víctor Mauricio Herrera, Juan Guillermo Pérez Carreño, Eliana Váquiro Herrera, Yeny Zulay Castellanos Domínguez, Skarlet Marcell Vásquez, Zulma Milena Cucunubá, Nilda Graciela Prado, and Yolanda Hernández. Nifurtimox Versus Benznidazole or Placebo for Asymptomatic Trypanosoma Cruzi Infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): Study Protocol for a Randomised Controlled Trial. 2019.

Cita MLA

Villar, Juan Carlos, et al. Nifurtimox Versus Benznidazole or Placebo for Asymptomatic Trypanosoma Cruzi Infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): Study Protocol for a Randomised Controlled Trial. 2019.